CareRay Digital Medical Technology Co., Ltd. (SHA:688607)
China · Delayed Price · Currency is CNY 52.36
-4.13 (-7.31%)
Mar 9, 2026, 3:00 PM CST
SHA:688607 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 320.53 | 288.88 | 267.68 | 197.4 | 328.05 |
Other Revenue | - | 9.22 | 6.06 | 7.18 | 13.93 |
| 320.53 | 298.1 | 273.74 | 204.57 | 341.98 | |
Revenue Growth (YoY) | 7.52% | 8.90% | 33.81% | -40.18% | 0.81% |
Cost of Revenue | - | 185.59 | 172.69 | 140.88 | 185.19 |
Gross Profit | 320.53 | 112.51 | 101.05 | 63.69 | 156.79 |
Selling, General & Admin | - | 58.18 | 54.96 | 52.91 | 46.5 |
Research & Development | - | 43.72 | 44.6 | 44.52 | 31.87 |
Other Operating Expenses | 331.28 | -0.58 | -0.44 | -0.58 | -1.57 |
Operating Expenses | 331.28 | 103.87 | 100.5 | 97.2 | 80.6 |
Operating Income | -10.76 | 8.63 | 0.56 | -33.51 | 76.19 |
Interest Expense | - | -0.75 | -0.51 | -0.37 | -0.21 |
Interest & Investment Income | - | 8.01 | 10.22 | 12.51 | 18.9 |
Currency Exchange Gain (Loss) | - | 1.04 | 2.97 | 10.27 | -1.26 |
Other Non Operating Income (Expenses) | -0.23 | 1.06 | -1.12 | -0.55 | -0.44 |
EBT Excluding Unusual Items | -10.98 | 17.99 | 12.12 | -11.65 | 93.17 |
Gain (Loss) on Sale of Investments | - | -1.15 | 1.41 | 0.11 | -0.34 |
Gain (Loss) on Sale of Assets | - | -0 | 0.19 | -0.04 | - |
Asset Writedown | - | -0.02 | - | - | - |
Legal Settlements | - | -0.01 | - | - | - |
Other Unusual Items | - | 0.87 | 1.58 | 2.67 | 3.44 |
Pretax Income | -10.98 | 17.69 | 15.3 | -8.91 | 96.28 |
Income Tax Expense | -3.88 | 0.01 | -0.11 | -3.23 | 11.23 |
Earnings From Continuing Operations | -7.1 | 17.68 | 15.41 | -5.68 | 85.05 |
Minority Interest in Earnings | - | -0.02 | 0 | 0.05 | 0.04 |
Net Income | -7.1 | 17.65 | 15.41 | -5.63 | 85.09 |
Net Income to Common | -7.1 | 17.65 | 15.41 | -5.63 | 85.09 |
Net Income Growth | - | 14.54% | - | - | 13.23% |
Shares Outstanding (Basic) | - | 88 | 91 | 94 | 86 |
Shares Outstanding (Diluted) | - | 88 | 91 | 94 | 86 |
Shares Change (YoY) | - | -2.64% | -3.38% | 9.18% | 30.39% |
EPS (Basic) | - | 0.20 | 0.17 | -0.06 | 0.99 |
EPS (Diluted) | - | 0.20 | 0.17 | -0.06 | 0.99 |
EPS Growth | - | 17.65% | - | - | -13.16% |
Free Cash Flow | - | -73.59 | -21.71 | -55.89 | 17.46 |
Free Cash Flow Per Share | - | -0.83 | -0.24 | -0.60 | 0.20 |
Dividend Per Share | - | 0.061 | 0.054 | - | - |
Dividend Growth | - | 12.96% | - | - | - |
Gross Margin | 100.00% | 37.74% | 36.92% | 31.13% | 45.85% |
Operating Margin | -3.36% | 2.90% | 0.20% | -16.38% | 22.28% |
Profit Margin | -2.21% | 5.92% | 5.63% | -2.75% | 24.88% |
Free Cash Flow Margin | - | -24.69% | -7.93% | -27.32% | 5.11% |
EBITDA | -8.13 | 11.26 | 6.71 | -27 | 82.3 |
EBITDA Margin | -2.54% | 3.78% | 2.45% | -13.20% | 24.06% |
D&A For EBITDA | 2.63 | 2.63 | 6.15 | 6.51 | 6.11 |
EBIT | -10.76 | 8.63 | 0.56 | -33.51 | 76.19 |
EBIT Margin | -3.36% | 2.90% | 0.20% | -16.38% | 22.28% |
Effective Tax Rate | - | 0.06% | - | - | 11.66% |
Revenue as Reported | - | 298.1 | 273.74 | 204.57 | 341.98 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.